MeiraGTx Holdings plc — 四半期キャッシュフロー (NASDAQ:MGTX) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 269.75 M224.01 M198.72 M189.47 M244.43 M 負債合計 201.92 M190.91 M195.76 M230.03 M250.22 M 純資産合計 67.83 M33.1 M2.96 M-40.56 M-5.79 M 負債および純資産合計 269.75 M224.01 M198.72 M189.47 M244.43 M 有利子負債合計 73.22 M73.5 M73.77 M88.06 M74.38 M 純負債 -30.44 M6.97 M41.61 M73.22 M8.44 M

ニュース

MeiraGTx: Turning Dry Mouth Into Liquid Gold (NASDAQ:MGTX)

Strength Seen in MeiraGTx (MGTX): Can Its 6.2% Jump Turn into More Strength?

MeiraGTx Holdings plc (MGTX) Presents at RBC Capital Markets Virtual Ophthalmology Conference Transcript

X4 Pharmaceuticals (XFOR) Reports Q4 Loss, Tops Revenue Estimates

Editas Medicine (EDIT) Reports Q4 Loss, Tops Revenue Estimates

Regenxbio (RGNX) Reports Q4 Loss, Lags Revenue Estimates

AnaptysBio, Inc. (ANAB) Q4 Earnings and Revenues Top Estimates

TG Therapeutics (TGTX) Misses Q4 Earnings Estimates

MeiraGTxの株価、ジオ・グループ治療薬のZipBioとの独占的ライセンス契約で上昇

MeiraGTx stock rises on exclusive licensing deal with ZipBio for eye disease therapy

MeiraGTxが地理的萎縮治療のためにZipBioのAI設計療法のライセンスを取得

MeiraGTx licenses ZipBio’s AI-designed therapies for geographic atrophy